Evaluation of total tumor volume reduction ratio in initially unresectable colorectal liver metastases after first line treatment
Keywords:
colorectal liver metastases, conversion therapy, total tumor volume, reduction ratioAbstract
Background: Total tumour volume is predictive factor for hepatic resection in some solid tumours, but its significance in colorectal liver metastases has not been fully investigated. liver is most frequent location of distant metastasis for colorectal cancer, which is 1 of most common cancers to cause cancer-related deaths globally. For colorectal liver metastases, hepatic resection is widely recognized as most effective therapy & only possibly curative operation. assessment of tumour burden can depend significantly on total tumour volume. Aim: In this review, we sought to assess the total tumour volume decrease ratio in colorectal liver metastases that were initially unresectable following 1st-line therapy, Summary: After receiving 1st-line systemic therapy, decreased ratio of TTV had been reliable predictor of conversion result & long-term prognosis in studied cases with originally unresectable CRLM.
Downloads
References
Robles-Campos, R., Lopez-Lopez, V., Brusadin, R., Lopez-Conesa, A., Gil-Vazquez, P. J., Navarro-Barrios, Á., et al. (2019). Open versus minimally invasive liver surgery for colorectal liver metastases (LapOpHuva): a prospective randomized controlled trial. Surgical Endoscopy, 33, 3926–3936.
Mulcahy, M. F., Mahvash, A., Pracht, M., Montazeri, A. H., Bandula, S., Martin, R. C. G., et al. (2021). Radioembolization with chemotherapy for colorectal liver metastases: a randomized, open-label, international, multicenter, phase III trial. Journal of Clinical Oncology, 39(35), 3897–3907.
Syn, N. L., Kabir, T., Koh, Y. X., Tan, H. L., Wang, L. Z., Chin, B. Z., et al. (2020). Survival advantage of laparoscopic versus open resection for colorectal liver metastases: a meta-analysis of individual patient data from randomized trials and propensity-score matched studies. Annals of Surgery, 272(2), 253–265.
Hashiguchi, Y., Muro, K., Saito, Y., Ito, Y., Ajioka, Y., Hamaguchi, T., et al. (2020). Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. International Journal of Clinical Oncology, 25, 1–42.
Takahashi, H., Berber, E. (2020). Role of thermal ablation in the management of colorectal liver metastasis. Hepatobiliary Surgery and Nutrition, 9(1), 49.
Edhemovic, I., Brecelj, E., Cemazar, M., Boc, N., Trotovsek, B., Djokic, M., et al. (2020). Intraoperative electrochemotherapy of colorectal liver metastases: a prospective phase II study. European Journal of Surgical Oncology, 46(9), 1628–1633.
Bonney, G. K., Chew, C. A., Lodge, P., Hubbard, J., Halazun, K. J., Trunecka, P., et al. (2021). Liver transplantation for non-resectable colorectal liver metastases: the International Hepato-Pancreato-Biliary Association consensus guidelines. The Lancet Gastroenterology & Hepatology, 6(11), 933–946.
Oki, E., Emi, Y., Yamanaka, T., Uetake, H., Muro, K., Takahashi, T., et al. (2019). Randomised phase II trial of mFOLFOX6 plus bevacizumab versus mFOLFOX6 plus cetuximab as first-line treatment for colorectal liver metastasis (ATOM trial). British Journal of Cancer, 121(3), 222–229.
Mao, Y., Chen, B., Wang, H., Zhang, Y., Yi, X., Liao, W., et al. (2020). Diagnostic performance of magnetic resonance imaging for colorectal liver metastasis: A systematic review and meta-analysis. Scientific Reports, 10(1), 1969.
Moris, D., Tsilimigras, D. I., Machairas, N., Merath, K., Cerullo, M., Hasemaki, N., et al. (2019). Laparoscopic synchronous resection of colorectal cancer and liver metastases: a systematic review. Journal of Surgical Oncology, 119(1), 30–39.
Jensen, C. T., Wagner-Bartak, N. A., Vu, L. N., Liu, X., Raval, B., Martinez, D., et al. (2019). Detection of colorectal hepatic metastases is superior at standard radiation dose CT versus reduced dose CT. Radiology, 290(2), 400–409.
Imai, K., Adam, R., Baba, H. (2019). How to increase the resectability of initially unresectable colorectal liver metastases: A surgical perspective. Annals of Gastroenterological Surgery, 3(5), 476–486.
He, J., Li, W., Zhou, J., Sun, H., Zhou, C., Liu, Y., et al. (2023). Evaluation of total tumor volume reduction ratio in initially unresectable colorectal liver metastases after first-line systemic treatment. European Journal of Radiology, 110950.
Published
How to Cite
Issue
Section
Copyright (c) 2023 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
